These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22994085)

  • 21. Circulating TNFRI and TNFRII levels correlated with the disease activity score (DAS28) in rheumatoid arthritis.
    Valle Y; Ledezma-Lozano IY; Torres-Carrillo N; Padilla-Gutiérrez JR; Navarro-Hernández RE; Vázquez-Del Mercado M; Palafox-Sánchez CA; Armendáriz-Borunda J; Muñoz-Valle JF
    Scand J Rheumatol; 2009; 38(5):332-5. PubMed ID: 19579138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
    Kluz J; Kopeć W; Jakobsche-Policht U; Adamiec R
    Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Serum tumor necrosis factor alpha (TNF-alpha) concentration correlates with soluble adhesion molecules and vascular endothelial growth factor (VEGF) in rheumatoid arthritis].
    Klimiuk PA; Sierakowski S; Fiedorczyk M; Chwiećko J
    Przegl Lek; 2004; 61(2):86-9. PubMed ID: 15230147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Serum soluble adhesion molecules--sICAM-1, sVCAM-1, sE-selectin--in patients with systemic rheumatoid arthritis].
    Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S
    Pol Merkur Lekarski; 2004 Oct; 17(100):353-6. PubMed ID: 15690700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Markers of endothelial dysfunction (VCAM-1 and vWF) in chronic hepatitis C].
    Antonova TV; Romanova MA; Lymar' IuV
    Ter Arkh; 2013; 85(12):86-9. PubMed ID: 24640675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical associations of C-reactive protein in systemic sclerosis].
    Alekperov RT; Baranov AA; Abaĭtova NE
    Ter Arkh; 2006; 78(6):30-5. PubMed ID: 16881360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients.
    Hjeltnes G; Hollan I; Førre Ø; Wiik A; Mikkelsen K; Agewall S
    Scand J Rheumatol; 2011 Nov; 40(6):422-7. PubMed ID: 22150462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment.
    Lal P; Su Z; Holweg CT; Silverman GJ; Schwartzman S; Kelman A; Read S; Spaniolo G; Monroe JG; Behrens TW; Townsend MJ
    Arthritis Rheum; 2011 Dec; 63(12):3681-91. PubMed ID: 22127691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased levels of interleukin-33 associated with bone erosion and interstitial lung diseases in patients with rheumatoid arthritis.
    Xiangyang Z; Lutian Y; Lin Z; Liping X; Hui S; Jing L
    Cytokine; 2012 Apr; 58(1):6-9. PubMed ID: 22239947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of spironolactone on endothelial dysfunction in rheumatoid arthritis.
    Syngle A; Vohra K; Kaur L; Sharma S
    Scand J Rheumatol; 2009; 38(1):15-22. PubMed ID: 18766955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles of claudin-5 and von Willebrand factor in patients with rheumatoid arthritis.
    Gurol G; Ciftci IH; Harman H; Karakece E; Kamanli A; Tekeoglu I
    Int J Clin Exp Pathol; 2015; 8(2):1979-84. PubMed ID: 25973092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum IL-6 and IL-21 are associated with markers of B cell activation and structural progression in early rheumatoid arthritis: results from the ESPOIR cohort.
    Gottenberg JE; Dayer JM; Lukas C; Ducot B; Chiocchia G; Cantagrel A; Saraux A; Roux-Lombard P; Mariette X
    Ann Rheum Dis; 2012 Jul; 71(7):1243-8. PubMed ID: 22532637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased arterial stiffness and indication of endothelial dysfunction in long-standing rheumatoid arthritis.
    Wållberg-Jonsson S; Caidahl K; Klintland N; Nyberg G; Rantapää-Dahlqvist S
    Scand J Rheumatol; 2008; 37(1):1-5. PubMed ID: 18189187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral glucose tolerance test effects on endothelial inflammation markers in healthy subjects and diabetic patients.
    Derosa G; D'Angelo A; Salvadeo SA; Ferrari I; Fogari E; Gravina A; Mereu R; Palumbo I; Maffioli P; Randazzo S; Cicero AF
    Horm Metab Res; 2010 Jan; 42(1):8-13. PubMed ID: 19735057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P-selectin as a circulating molecular marker in rheumatoid arthritis with thrombocytosis.
    Ertenli I; Kiraz S; Arici M; Haznedaroglu IC; Calgüneri M; Celik I; Kirazli S
    J Rheumatol; 1998 Jun; 25(6):1054-8. PubMed ID: 9632062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function.
    Nelson CL; Karschimkus CS; Dragicevic G; Packham DK; Wilson AM; O'Neal D; Becker GJ; Best JD; Jenkins AJ
    Nephrol Dial Transplant; 2005 Nov; 20(11):2420-6. PubMed ID: 16115854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. von Willebrand factor and endothelial damage in essential hypertension.
    Blann AD; Naqvi T; Waite M; McCollum CN
    J Hum Hypertens; 1993 Apr; 7(2):107-11. PubMed ID: 8510081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible evidence of endothelial cell activation and disturbance in thalassemia: an in vitro study.
    Butthep P; Bunyaratvej A; Funahara Y; Kitaguchi H; Fucharoen S; Sato S; Bhamarapravati N
    Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 3():141-148A. PubMed ID: 9640617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Angiotensin-converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with longterm rheumatoid arthritis.
    Tikiz C; Utuk O; Pirildar T; Bayturan O; Bayindir P; Taneli F; Tikiz H; Tuzun C
    J Rheumatol; 2005 Nov; 32(11):2095-101. PubMed ID: 16265685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction.
    Jezovnik MK; Poredos P
    Int Angiol; 2010 Jun; 29(3):226-31. PubMed ID: 20502419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.